Published in Thromb J on January 23, 2015
Platelet Inhibition in Patients With Systolic Heart Failure | NCT01765400
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med (2001) 20.20
Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med (2009) 18.03
Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med (2007) 17.85
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet (1996) 16.32
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA (2002) 11.06
Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med (2005) 5.28
Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives. J Am Coll Cardiol (2007) 2.73
Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data. J Am Coll Cardiol (2011) 2.05
Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention. Circulation (2005) 2.05
The effect of pre-analytical variables on light transmittance aggregometry in citrated platelet-rich plasma from healthy subjects. Clin Chem Lab Med (2010) 1.54
Platelet count and platelet activation: impact of a fat meal and day time. Platelets (2007) 1.46
Results of a worldwide survey on the assessment of platelet function by light transmission aggregometry: a report from the platelet physiology subcommittee of the SSC of the ISTH. J Thromb Haemost (2009) 1.18
Pharmacokinetics and pharmacodynamics of a bolus and infusion of cangrelor: a direct, parenteral P2Y12 receptor antagonist. J Clin Pharmacol (2009) 0.99
Effect of a diet of polyunsaturated fats on some platelet-function tests. Lancet (1976) 0.98
Platelet functions in relation to dietary fats in farmers from two regions of France. Thromb Haemost (1979) 0.93
The effect of alimentary hyperlipaemia and primary hypertriglyceridaemia on platelets in man. Scand J Haematol (1974) 0.89
Clopidogrel pharmacodynamics and pharmacokinetics in the fed and fasted state: a randomized crossover study of healthy men. J Clin Pharmacol (2011) 0.86
Considerable variability in platelet activity among patients with coronary artery disease in response to an increased maintenance dose of clopidogrel. Coron Artery Dis (2009) 0.86
Lipid infusions in man. Ultrastructural studies on blood platelet uptake of fat particles. Thromb Diath Haemorrh (1973) 0.81
High residual platelet reactivity on standard clopidogrel maintenance dose predicts increased responsiveness to the double-standard dose in an assay-dependent manner. Thromb Haemost (2011) 0.81
Increased platelet aggregation during alimentary hyperlipemia in normal and hypertriglyceridemic subjects. Ann Nutr Metab (1986) 0.79
Clopidogrel bioavailability: absence of influence of food or antacids. Semin Thromb Hemost (1999) 0.79
Platelets during alimentary hyperlipaemia induced by cream and cod liver oil. Eur J Clin Invest (1984) 0.78
Effect of postprandial lipaemia on platelet function in man evaluated in whole blood. Thromb Res (1987) 0.78
Chylomicrons from patients with type V hyperlipoproteinemia inhibit platelet function. Atherosclerosis (1985) 0.77
Acute effect of high-fat meals rich in either stearic or myristic acid on hemostatic factors in healthy young men. Am J Clin Nutr (1996) 0.77
Cost-effectiveness of universal and platelet reactivity assay-driven antiplatelet therapy in acute coronary syndrome. Am J Cardiol (2013) 0.77
Prevention of lipid induced platelet aggregation by aspirin. Thromb Res (1982) 0.77
Dietary fats and platelet function in French and Scottish farmers. Nutr Metab (1980) 0.77
Acute postprandial lipaemia does not influence the in vivo activity of human platelets. Thromb Res (1985) 0.77